UK Immunologist’s Contradictory Take on COVID-19 Vaccination & Children

A prominent British Immunologist and Professor in Biomedical Sciences and Public Engagement at the University of Manchester recently declared in an Op-Ed piece in The Guardian that British health authorities are deviating from the rest of the wealthy developed nations by not placing more emphasis on universal COVID-19 vaccination for children and young adults. Sheena Cruickshank argues that the risk-based approach to COVID-19 vaccination recommended by the UK Joint Committee on Vaccination and Immunization (JCVI)---that the vaccines are generally only available for high-risk groups deviates from the norm of wealthy peer nations. But is Cruickshank correct? Not really. The JCVI’s recommendations reflect more the norm among most developed nations. Even the New York Times would concur. Just read the recent “Covid Shots for Children.” David Leonhardt reports, “Much of the world has decided that most young children don’t need to receive Covid booster shots. The U.S. is an outlier.” Why is this the case? While the COVID jabs helped mitigate risk during the pandemic, now experts align for the most part that the benefits of these jabs for children in most cases “fail to outweigh the costs.”

Contrary to Professor Cruickshank’s stance, the U.S. is an outlier in this regard. And Britain’s JCVI actually follows most of the peer national COVID-19 vaccine policy, where healthy children are not included in the seasonal vaccination campaign.